---
figid: PMC10940631__41420_2023_1781_Fig3_HTML
figtitle: Compensatory relationship between the ubiquitinâ€’proteasome pathway and the
  autolysosome pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10940631
filename: 41420_2023_1781_Fig3_HTML.jpg
figlink: /pmc/articles/PMC10940631/figure/F3
number: F3
caption: Proteasome inhibitors can impede the degradation and accumulation of ubiquitinated
  proteins while also inducing autophagy through direct and indirect mechanisms, ultimately
  culminating in the apoptosis of cancer cells. In addition, inhibition of the autolysosome
  pathway through RNA interference and lysosomal inhibitor treatment can enhance proteasome
  activity and substrate protein degradation while also promoting cancer cell genesis
  and growth via p62 accumulation and its E3 ubiquitin ligase
papertitle: Role of protein degradation systems in colorectal cancer
reftext: Zihan Cui, et al. Cell Death Discov. 2024;10(NA).
year: '2024'
doi: 10.1038/s41420-023-01781-8
journal_title: Cell Death Discovery
journal_nlm_ta: Cell Death Discov
publisher_name: Nature Publishing Group UK
keywords: Colorectal cancer | Cell death
automl_pathway: 0.8925426
figid_alias: PMC10940631__F3
figtype: Figure
redirect_from: /figures/PMC10940631__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10940631__41420_2023_1781_Fig3_HTML.html
  '@type': Dataset
  description: Proteasome inhibitors can impede the degradation and accumulation of
    ubiquitinated proteins while also inducing autophagy through direct and indirect
    mechanisms, ultimately culminating in the apoptosis of cancer cells. In addition,
    inhibition of the autolysosome pathway through RNA interference and lysosomal
    inhibitor treatment can enhance proteasome activity and substrate protein degradation
    while also promoting cancer cell genesis and growth via p62 accumulation and its
    E3 ubiquitin ligase
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - MAP1LC3A
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - ULK1
  - IFI27
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - NFKBIA
  - CCND1
  - GTF2H1
  - SQSTM1
  - KHDRBS1
  - NUP62
  - DCTN4
  - CDKN1A
  - CDPF1
  - XIAP
  - NFKB1
  - proteins
  - Chloroquine
  - 'off'
  - cancer
---
